Partner Headlines - ILMN

  1. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  2. Several Big Cap 20 Names Near Buy Points

    IBD
  3. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  4. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  5. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  6. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  7. Novo, Other Medicals Display Healthy Action

    IBD
  8. 3 Hot Biotech Stocks Hitting Highs

    Benzinga
  9. Facebook Pops, But Key Indexes End Flat In Quiet Session

    IBD
  10. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  11. Stocks Hold Near Highs; Illumina Breakout Gains Traction

    IBD
  12. Stocks Build On Gains Backed By Strong Volume

    IBD
  13. Stocks Show Solid Gains At Midday

    IBD
  14. Stocks Reverse Into Thin Losses; Joy Global, Illumina Rocket

    IBD
  15. Five Star Biotech Stock Watch: Illumina

    Benzinga
  16. Baron Funds Comments on Illumina Inc.

    GuruFocus
  17. Baron Funds Comments on Illumina Inc.

    GuruFocus
  18. Valeant, Tesla Working On Bases As Energy Dominates

    IBD
  19. Baron Funds Comments on Illumina Inc.

    GuruFocus
  20. Nasdaq Recovers After Early Weakness; Apple Rallies Again

    IBD
  21. Illumina Reports Filing of New Patent Infringement Case Against ...

    Benzinga
  22. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  23. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  24. Gilead, Illumina Crush Views

    IBD
  25. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  26. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  27. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  28. How To Tweak Your Retirement Portfolio For 2014 Market

    IBD
  29. Medical Research Providers Ride Higher With Biotechs

    IBD
  30. Illumina, Alexion Lead 4 Big Caps Drawing Big Buyers

    IBD
  31. Gap-Ups Point To Strength Among Select Big Caps

    IBD
  32. Illumina Inc: How Long Can a Miracle Go On?

    GuruFocus
  33. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  34. Facebook, Biogen, Sands Among Top Big Caps Reporting

    IBD
  35. ILLUMINA

    IBD
  36. Illumina, Jazz Among 5 Young Guns Hitting New Highs

    IBD
  37. Illumina Details Its Strategy; Stock Jumps Again

    IBD
  38. US Stock Futures Surge Ahead Of Morgan Stanley Earnings

    Benzinga
  39. Illumina Announces New Organizational Alignment -8K

    Benzinga
  40. Market Wrap For January 16: Markets End Two Day Winning Streak

    Benzinga
  41. ILLUMINA

    IBD
  42. Illumina Upbeat On Q4, 2014

    IBD
  43. Illumina, Regeneron, Intuitive Q4 Results Impress

    IBD
  44. Year in Review: 2013 Innovations

    FoxBusiness
  45. Year in Review: 2013 Innovations

    FoxBusiness
  46. Benzinga's Top Initiations

    Benzinga
  47. Illumina Receives FDA Premarket Clearance for MiSeqDx System

    Benzinga
  48. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  49. Illumina Appoints Francis deSouza as President

    Benzinga
  50. Syntrix Biosystems Announces Court Upholds $115M Patent Infringement ...

    Benzinga
  51. Vipshop, 3D Systems Lead Top 5 Outperforming Stocks

    IBD
  52. Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing ...

    Benzinga
  53. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  54. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  55. Illumina Announces TruGenome Undiagnosed Disease Test

    Benzinga
  56. Illumina Tops Q3 Profit, Sales

    IBD
  57. Illumina Earnings, Guidance Beat Estimates Yet Again

    IBD
  58. Earnings Scheduled For October 21, 2013

    Benzinga
  59. Illumina Collaborates with University of Cambridge, Genomics ...

    Benzinga
  60. Illumina's Verinata Health Reports Expanded Test of Verifi for ...

    Benzinga
  61. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  62. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  63. Illumina Applies CE Mark to Expanded MiSeqDx™ System

    Benzinga
  64. Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 ...

    Benzinga
  65. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    Benzinga
  66. UPDATE: Wells Fargo Initiates Coverage on Illumina on Prime Market ...

    Benzinga
  67. Sony and Illumina Set to Change the Way Doctors Identify and ...

    Benzinga
  68. Illumina to Supply Natera with Sequencing Instruments, Consumables ...

    Benzinga
  69. Drug R&D Suppliers Deliver

    IBD
  70. Medical Research Firms Tap Drug Development Trend

    IBD
  71. Medical Research Firms Tap Drug Development Trend

    IBD
  72. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, ...

    Benzinga
  73. Illumina, Grifols, Acadia Resist The Correction

    IBD
  74. Benzinga's M&A Chatter for Monday August 12, 2013

    Benzinga
  75. Baron Funds Comments on Illumina Inc.

    GuruFocus
  76. Baron Funds Comments on Illumina Inc.

    GuruFocus
  77. PerkinElmer Stock Hits 12-Year High After Q2 Beat

    IBD
  78. Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

    Benzinga
  79. Education Companies Another Market Leader

    IBD
  80. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  81. UPDATE: Illumina Posts Higher Q4 Profit

    Benzinga
  82. Biogen MS Hopes Trump EPS

    IBD
  83. Stocks Turn Mixed, Apple Rises; Stratasys, 3D Systems Tumbling

    IBD
  84. Earnings Scheduled For January 28, 2013

    Benzinga
  85. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  86. Illumina, Inc. (ILMN) President & CEO Jay T Flatley sells 5, ...

    GuruFocus
  87. The Week Ahead: Earnings from Facebook, Ford, Caterpillar; US ...

    Benzinga
  88. Biogen, Illumina Ready Q4 Reports As Stocks Struggle

    IBD
  89. Life Technologies Stock Hits High On Buyout Rumors

    IBD
  90. Illumina, Inc. (ILMN) President & CEO Jay T Flatley sells 5, ...

    GuruFocus
  91. Benzinga's M&A Chatter for Tuesday January 8, 2013

    Benzinga
  92. Illumina plunges as talks falter

    IBD
  93. Benzinga's M&A Chatter for Monday January 7, 2013

    Benzinga
  94. Major Averages Record Small Losses to Start Week

    Benzinga
  95. Mid-Day Market Update: SolarCity Wins Big, SunPower Continues ...

    Benzinga
  96. UPDATE: Citigroup Reiterates Illumina at Neutral on Valuation

    Benzinga
  97. Mid-Morning Market Update: Markets Giving Back Some Gains, Big ...

    Benzinga
  98. Illumina Stock Falls As Roche Says Buyout Talks Fail

    IBD
  99. Stock Futures Take A Breather; Nationstar Mortgage Bolts Higher

    IBD
  100. Benzinga's Top Pre-Market Losers

    Benzinga
Trading Center